VENUNGOPAL, P., K. BALAKRISHNAN, D. K. SRIRAM, and M. GEORGE. “INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 12, Dec. 2022, pp. 42-46, doi:10.22159/ajpcr.2022.v15i12.46054.